Geode Capital Management, LLC Prelude Therapeutics Inc Put Options Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PRLD
# of Institutions
57Shares Held
28.3MCall Options Held
23.9KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$9.6 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$8.91 Million0.09% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$940,6460.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$888,0990.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD976KShares$859,0090.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $32M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...